Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London
Globe Newswire•29/10/2026•07:00 ET
0
Key Highlights
- ➤Minerva management to participate in 2026 Jefferies Global Healthcare Conference
- ➤Fireside chat scheduled for November 16, 2026, from 4:00–4:25 p.m. GMT
- ➤Minerva is conducting a confirmatory Phase 3 trial of roluperidone
BURLINGTON, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in the 2026 Jefferies Global Healthcare Conference in London.
2026 Jefferies Global Healthcare Conference Dates: Monday, November 16 & Tuesday, November 17, 2026 Format: Fireside chat and 1x1 meetings Fireside Chat: Monday, November 16, 2026 from 4:00 – 4:25 p.m. GMT Location: London, UK
Get started
Create a free account to read the full story.